Axogen (AXGN) Price to Sales (2011 - 2026)

Axogen has reported Price to Sales for 16 years, with the latest figure at 35.54 in Q2 2026.

• On a quarterly basis, Price to Sales rose 305.57% year-over-year to 35.54 in Q2 2026; TTM through Jun 2026 was 9.87, a 303.93% increase from a year earlier, with the FY2025 full-year figure at 6.86, up 76.62% from the prior year.
• Price to Sales was 35.54 for Q2 2026 at Axogen, up from 28.65 in the prior quarter.
• The five-year high for Price to Sales was 35.54 in Q2 2026, with the low at 5.21 in Q3 2023.
• Average Price to Sales over 5 years is 13.99, with a median of 11.37 recorded in 2023.
• The sharpest annual moves came in 2022 and 2026: Price to Sales slumped 62.35% in 2022, then jumped 305.57% in 2026.
• Over 5 years, Price to Sales stood at 11.71 in 2022, then slumped by 41.42% to 6.86 in 2023, then soared by 114.61% to 14.73 in 2024, then surged by 75.12% to 25.79 in 2025, then jumped by 37.82% to 35.54 in 2026.
• The last three Price to Sales figures came in at 35.54 (Q2 2026), 28.65 (Q1 2026), and 25.79 (Q4 2025), per Business Quant data.